FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386593359> ?p ?o ?g. }

• W4386593359 endingPage "31" @default.
• W4386593359 startingPage "21" @default.
• W4386593359 abstract "Angiotensin-converting enzyme 2 (ACE2) is a key component of the renin-angiotensin system (RAS), providing counter-regulation of its effects and, simultaneously, a receptor for the SARS-CoV-2 entering. It is suggested that factors regulating the balance of the major components of RAS, including ACE2 gene polymorphism, therapy with RAS blockers (ACE inhibitors and angiotensin receptor blockers) - may affect the severity of COVID-19.The aim of the study was to investigate the effect of RAS components, the relationship of ACE2 gene polymorphism rs2106809 and ACEi/ARBs therapy with the COVID-19 severity.The study included patients with COVID-19 hospitalized in Endocrinology research centre (n = 173), who were divided into groups of moderate and severe course. Determination of RAS components was performed by ELISA, identification of polymorphism by PCR. Statistical analysis was performed using nonparametric statistical methods; differences in the distribution of genotype frequencies were assessed using Fisher's exact test χ2.The groups differed significantly in age, blood glucose levels, and inflammatory markers: leukocytes, neutrophils, IL-6, D-dimer, C-reactive protein, ferritin and liver enzymes, which correlated with the severity of the disease. When comparing patients in terms of ACE, ACE2, angiotensin II, ADAM17 there were no statistically significant differences between the groups (p=0.544, p=0.054, p=0.836, p=1.0, respectively), including the distribution by gender (in men: p=0.695, p=0.726, p=0.824, p=0.512; in women: p=0.873, p=0.196, p=0.150, p=0.937). Analysis of the distribution of AA, AG, and GG genotypes of the rs2106809 polymorphism of the ACE2 gene also revealed no differences between patients: χ2 1.35, p=0.071 in men, χ2 5.28, p=0.244 in women. There were no significant differences in the use of RAS blockers between groups with different course severity: χ2 0.208, p=0.648 for ACEi, χ2 1.15, p=0.283 for ARBs.In our study, the influence of activation of RAS components (ACE, ACE2, AT II, ADAM17) and ACE2 gene polymorphism on the severity of COVID-19 course was not confirmed. The severity of COVID-19 course correlated with the level of standard inflammatory markers, indicating the general principles of the infection as a systemic inflammation, regardless of the genetic and functional status of the RAS." @default.
• W4386593359 created "2023-09-12" @default.
• W4386593359 creator A5007280664 @default.
• W4386593359 creator A5015451300 @default.
• W4386593359 creator A5035859311 @default.
• W4386593359 creator A5040976739 @default.
• W4386593359 creator A5049698833 @default.
• W4386593359 creator A5049701457 @default.
• W4386593359 creator A5060633744 @default.
• W4386593359 creator A5073526351 @default.
• W4386593359 creator A5081563369 @default.
• W4386593359 date "2023-08-30" @default.
• W4386593359 modified "2023-10-17" @default.
• W4386593359 title "Effect of components of the renin-angiotensin system, rs2106809 polymorphism of the <i>ACE2</i> gene, and therapy with RAS blockers on the severity of COVID-19" @default.
• W4386593359 cites W1966238900 @default.
• W4386593359 cites W1998964868 @default.
• W4386593359 cites W2001411396 @default.
• W4386593359 cites W2037927640 @default.
• W4386593359 cites W2096352923 @default.
• W4386593359 cites W2099131776 @default.
• W4386593359 cites W2156835140 @default.
• W4386593359 cites W2441391782 @default.
• W4386593359 cites W2521741120 @default.
• W4386593359 cites W2755474558 @default.
• W4386593359 cites W2898979898 @default.
• W4386593359 cites W3009335299 @default.
• W4386593359 cites W3012725239 @default.
• W4386593359 cites W3016572296 @default.
• W4386593359 cites W3023787531 @default.
• W4386593359 cites W3031959493 @default.
• W4386593359 cites W3033263367 @default.
• W4386593359 cites W3048711497 @default.
• W4386593359 cites W3174411711 @default.
• W4386593359 cites W3210549110 @default.
• W4386593359 cites W4311129551 @default.
• W4386593359 doi "https://doi.org/10.14341/probl13274" @default.
• W4386593359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37694864" @default.
• W4386593359 hasPublicationYear "2023" @default.
• W4386593359 type Work @default.
• W4386593359 citedByCount "0" @default.
• W4386593359 crossrefType "journal-article" @default.
• W4386593359 hasAuthorship W4386593359A5007280664 @default.
• W4386593359 hasAuthorship W4386593359A5015451300 @default.
• W4386593359 hasAuthorship W4386593359A5035859311 @default.
• W4386593359 hasAuthorship W4386593359A5040976739 @default.
• W4386593359 hasAuthorship W4386593359A5049698833 @default.
• W4386593359 hasAuthorship W4386593359A5049701457 @default.
• W4386593359 hasAuthorship W4386593359A5060633744 @default.
• W4386593359 hasAuthorship W4386593359A5073526351 @default.
• W4386593359 hasAuthorship W4386593359A5081563369 @default.
• W4386593359 hasBestOaLocation W43865933591 @default.
• W4386593359 hasConcept C104317684 @default.
• W4386593359 hasConcept C126322002 @default.
• W4386593359 hasConcept C134018914 @default.
• W4386593359 hasConcept C135763542 @default.
• W4386593359 hasConcept C149737253 @default.
• W4386593359 hasConcept C170493617 @default.
• W4386593359 hasConcept C198710026 @default.
• W4386593359 hasConcept C203014093 @default.
• W4386593359 hasConcept C27016395 @default.
• W4386593359 hasConcept C2775946041 @default.
• W4386593359 hasConcept C2779134260 @default.
• W4386593359 hasConcept C2908929049 @default.
• W4386593359 hasConcept C2910553456 @default.
• W4386593359 hasConcept C3008058167 @default.
• W4386593359 hasConcept C524204448 @default.
• W4386593359 hasConcept C54355233 @default.
• W4386593359 hasConcept C55775858 @default.
• W4386593359 hasConcept C71924100 @default.
• W4386593359 hasConcept C76252995 @default.
• W4386593359 hasConcept C84393581 @default.
• W4386593359 hasConcept C86803240 @default.
• W4386593359 hasConcept C98274493 @default.
• W4386593359 hasConceptScore W4386593359C104317684 @default.
• W4386593359 hasConceptScore W4386593359C126322002 @default.
• W4386593359 hasConceptScore W4386593359C134018914 @default.
• W4386593359 hasConceptScore W4386593359C135763542 @default.
• W4386593359 hasConceptScore W4386593359C149737253 @default.
• W4386593359 hasConceptScore W4386593359C170493617 @default.
• W4386593359 hasConceptScore W4386593359C198710026 @default.
• W4386593359 hasConceptScore W4386593359C203014093 @default.
• W4386593359 hasConceptScore W4386593359C27016395 @default.
• W4386593359 hasConceptScore W4386593359C2775946041 @default.
• W4386593359 hasConceptScore W4386593359C2779134260 @default.
• W4386593359 hasConceptScore W4386593359C2908929049 @default.
• W4386593359 hasConceptScore W4386593359C2910553456 @default.
• W4386593359 hasConceptScore W4386593359C3008058167 @default.
• W4386593359 hasConceptScore W4386593359C524204448 @default.
• W4386593359 hasConceptScore W4386593359C54355233 @default.
• W4386593359 hasConceptScore W4386593359C55775858 @default.
• W4386593359 hasConceptScore W4386593359C71924100 @default.
• W4386593359 hasConceptScore W4386593359C76252995 @default.
• W4386593359 hasConceptScore W4386593359C84393581 @default.
• W4386593359 hasConceptScore W4386593359C86803240 @default.
• W4386593359 hasConceptScore W4386593359C98274493 @default.
• W4386593359 hasIssue "4" @default.
• W4386593359 hasLocation W43865933591 @default.
• W4386593359 hasLocation W43865933592 @default.

• next